In the Clinic Dyslipidemia

被引：57
作者：
Arvanitis, Marios [1 ]
Lowenstein, Charles J. [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2023年 / 176卷 / 06期
关键词：
DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; FOLLOW-UP; RISK; MANAGEMENT; STATINS; SAFETY; WOMEN;
D O I：
10.7326/AITC202306200
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Dyslipidemia is an important risk factor for coronary artery disease and stroke. All persons with dyslipidemia should be advised to focus on lifestyle interventions, including regular aerobic exercise, a healthy diet, maintenance of a healthy weight, and abstinence from smoking. In addition to lifestyle interventions, lipid-lowering therapy should be considered for persons at moderate to high risk for atherosclerotic cardiovascular disease based on validated risk equations. Statin therapy is the first-line medical treatment for dyslipidemia due to its effectiveness and favorable adverse effect profile, but newer treatments provide additional tools for clinicians to effectively treat dyslipidemia.
引用
收藏
页码：ITC81 / U191
页数：17
相关论文
共 54 条
  • [1] CHOLESTEROL AND MORTALITY - 30 YEARS OF FOLLOW-UP FROM THE FRAMINGHAM-STUDY
    ANDERSON, KM
    CASTELLI, WP
    LEVY, D
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (16): : 2176 - 2180
  • [2] Arnett DK, 2019, CIRCULATION, V140, pE563, DOI [10.1161/CIR.0000000000000677, 10.1161/CIR.0000000000000678, 10.1016/j.jacc.2019.03.009, 10.1016/j.jacc.2019.03.010]
  • [3] AUSTIN MA, 1992, AM J HUM GENET, V51, P829
  • [4] Bailen Almorox R, 2012, Rev Clin Esp, V212, P408
  • [5] Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
    Bhatt, Deepak L.
    Steg, P. Gabriel
    Miller, Michael
    Brinton, Eliot A.
    Jacobson, Terry A.
    Ketchum, Steven B.
    Doyle, Ralph T., Jr.
    Juliano, Rebecca A.
    Jiao, Lixia
    Granowitz, Craig
    Tardif, Jean-Claude
    Ballantyne, Christie M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (01) : 11 - 22
  • [6] Statin Use for the Primary Prevention of Cardiovascular Disease in Adults US Preventive Services Task Force Recommendation Statement
    Bibbins-Domingo, Kirsten
    Grossman, David C.
    Curry, Susan J.
    Davidson, KarinaW.
    Epling, John W., Jr.
    Garcia, Francisco A. R.
    Gillman, Matthew W.
    Kemper, Alex R.
    Krist, Alex H.
    Kurth, Ann E.
    Landefeld, C. Seth
    LeFevre, Michael L.
    Mangione, Carol M.
    Phillips, William R.
    Owens, Douglas K.
    Phipps, Maureen G.
    Pignone, Michael P.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (19): : 1997 - 2007
  • [7] A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
    Blom, Dirk J.
    Hala, Tomas
    Bolognese, Michael
    Lillestol, Michael J.
    Toth, Phillip D.
    Burgess, Lesley
    Ceska, Richard
    Roth, Eli
    Koren, Michael J.
    Ballantyne, Christie M.
    Monsalvo, Maria Laura
    Tsirtsonis, Kate
    Kim, Jae B.
    Scott, Rob
    Wasserman, Scott M.
    Stein, Evan A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (19) : 1809 - 1819
  • [8] Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
    Cannon, Christopher P.
    Blazing, Michael A.
    Giugliano, Robert P.
    McCagg, Amy
    White, Jennifer A.
    Theroux, Pierre
    Darius, Harald
    Lewis, Basil S.
    Ophuis, Ton Oude
    Jukema, J. Wouter
    De Ferrari, Gaetano M.
    Ruzyllo, Witold
    De Lucca, Paul
    Im, KyungAh
    Bohula, Erin A.
    Reist, Craig
    Wiviott, Stephen D.
    Tershakovec, Andrew M.
    Musliner, Thomas A.
    Braunwald, Eugene
    Califf, Robert M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (25) : 2387 - 2397
  • [9] Blood cholesterol screening - Influence of fasting state on cholesterol results and management decisions
    Craig, SR
    Amin, RV
    Russell, DW
    Paradise, NF
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2000, 15 (06) : 395 - 399
  • [10] Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors US Preventive Services Task Force Recommendation Statement
    Curry, Susan J.
    Krist, Alex H.
    Owens, Douglas K.
    Barry, Michael J.
    Caughey, Aaron B.
    Davidson, KarinaW.
    Doubeni, Chyke A.
    Epling, John W., Jr.
    Kemper, Alex R.
    Kubik, Martha
    Landefeld, Seth
    Mangione, Carol M.
    Silverstein, Michael
    Simon, Melissa A.
    Tseng, Chien-Wen
    Wong, John B.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (03): : 272 - 280
123456